一项为期八年的前瞻性对照研究:常规起搏器或常规植入式心律转复除颤器患者接受心脏与非心脏1.5-T MRI的安全性和诊断价值
这项为期八年的前瞻性对照研究比较了携带常规起搏器(cPM)或常规植入式心律转复除颤器(cICD)的患者接受1.5-T MRI(研究组)与接受胸部X线、CT或随访(对照组)的情况。研究组共120例患者完成142次MRI(其中心脏MRI 55次),未观察到不良事件,所有设备在MRI后均被正确重新编程且无故障。非心脏MRI中99%(86/87)可诊断,但心脏MRI在cICD携带者中23%(9/40)无法诊断。
要点
- 携带cPM或cICD的患者在放射科与心脏电生理科合作下接受1.5-T MRI未发生不良事件。
- 非心脏MRI在cPM/cICD携带者中99%(86/87)可诊断,其中82/87无伪影。
- cPM携带者心脏MRI全部有伪影,14/15可诊断、1/15部分可诊断;cICD携带者心脏MRI 9/40可诊断、22/40部分可诊断、9/40无法诊断。
核心结论
- 1.5-T MRI在cPM/cICD携带者中表现出有利的风险-获益比。
研究设计与样本
- 前瞻性对照研究,研究组为接受MRI的cPM/cICD携带者(排除设备依赖者、入组前6周内植入者或2000年1月1日前植入者),对照组为接受胸部X线、CT或随访的cPM/cICD携带者;研究组120例患者(cPM 71例、cICD 71例)完成142次MRI(其中心脏MRI 55次),对照组95例患者(cPM 40例、cICD 58例)完成98次测量;设备为1.5-T MRI。
关键影像表现/征象
- 非心脏MRI:82/87无伪影可诊断,4/87有伪影但可诊断,1/87部分可诊断。
- cPM携带者心脏MRI:14/15有伪影但可诊断,1/15部分可诊断。
- cICD携带者心脏MRI:9/40有伪影但可诊断,22/40部分可诊断,9/40无法诊断。
诊断标准与关键数值
- MRI后即刻设备询问参数:14项中12项无显著变化(电池电压和cICD充电时间有临床可忽略的变化),研究组与对照组之间无显著差异。
- MRI后3-12个月设备询问参数:11项中9项无显著变化(电池阻抗/电压有临床可忽略的变化)。
- 心肌坏死三项标志物无显著变化。
临床应用与阅片要点
- 放射科与心脏电生理科合作可使cPM/cICD携带者安全接受1.5-T MRI。
- 所有cPM/cICD在MRI后均被正确重新编程且无故障,仅1例cPM携带者出现一次临时通讯故障。
- 非心脏MRI在cPM/cICD携带者中绝大多数可诊断;心脏MRI在cICD携带者中约23%无法诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD).
METHODS: We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG).
RESULTS: 142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three-12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic.
CONCLUSIONS: A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.
KEY POINTS: • Cooperation between radiologists and cardiac electrophysiologists allowed safe 1.5-T MRI in cPM/cICD-carriers. • No adverse events for 142 MRI in 71 cPM-carriers and 71 cICD-carriers. • Ninety-nine per cent (86/87) of non-cardiac MRI in cPM/cICD-carriers were diagnostic. • All cPM-carrier cardiac MRIs had artefacts, 14 examinations diagnostic, 1 partially diagnostic. • Twenty-three per cent (9/40) of cardiac MRI in cICD-carriers were non-diagnostic.
引用
- Lupo P, Cappato R, Di Leo G, et al. An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator. Eur Radiol. 2018. PMID: 29318430. doi:10.1007/s00330-017-5098-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。